FULC
NASDAQ · Pharmaceuticals
Fulcrum Therapeutics Inc
$3.71
-0.06 (-1.59%)
Open$3.74
Previous Close$3.77
Day High$3.76
Day Low$3.68
52W High$15.74
52W Low$2.83
Volume—
Avg Volume1.29M
Market Cap283.83M
P/E Ratio—
EPS$-0.90
SectorPharmaceuticals
Analyst Ratings
Sell
11 analysts
Price Target
+1,435.8% upside
Current
$3.71
$3.71
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 88.39M | 54.89M | 366.88M |
| Net Income | -10,744,616 | -6,005,188 | 47.13M |
| Profit Margin | -12.2% | -11.6% | 12.9% |
| EBITDA | -8,984,663 | -5,300,521 | 69.95M |
| Free Cash Flow | — | — | 54.75M |
| Rev Growth | +61.0% | +61.0% | +22.0% |
| Debt/Equity | — | — | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |